In the US ICD-10-CM code set, a high platelet count with no confirmed cause is coded as D75.839 (thrombocytosis, unspecified). Reactive or secondary thrombocytosis goes under D75.838 (other thrombocytosis), and essential thrombocythemia, a bone marrow neoplasm, has its own code, D47.3. The right code depends on why the platelet count is high, so the diagnostic work-up and the coding go hand in hand.
Older versions of this page gave D75.1 as the code, which is wrong: D75.1 is secondary polycythemia, a red cell problem. Below I cover how the codes are organized, what counts as a high count, the usual causes, and how clinicians decide between primary and secondary thrombocytosis.
What Counts as a High Platelet Count?
In adults, platelets normally range from about 150,000 to 450,000 per microliter of blood. A count above 450,000/µL is called thrombocytosis. Platelets are small cell fragments that start blood clotting. When there are too many of them, the risk of clotting goes up. In some people, especially with very high counts, the risk of bleeding goes up too.
Laboratories report platelet levels as a number per microliter or as ×10⁹/L, and the two mean the same thing: 450 ×10⁹/L equals 450,000/µL. Each lab sets its own reference range, so always read your result against the range printed on your report. For a wider look at what affects the count, see our guide to managing platelet levels.
ICD-10 Codes for High Platelet Count
No single code covers every high platelet count. The code has to match the diagnosis the clinician has documented. The table lists the codes used most often for thrombocytosis and related conditions in ICD-10-CM.
| Code | Description | When it is typically used |
|---|---|---|
| D75.839 | Thrombocytosis, unspecified | High platelet count with the cause not yet determined |
| D75.838 | Other thrombocytosis | Reactive or secondary thrombocytosis, such as after infection, surgery, or splenectomy |
| D47.3 | Essential (hemorrhagic) thrombocythemia | Confirmed essential thrombocythemia, a myeloproliferative neoplasm |
| D75.1 | Secondary polycythemia | Not a platelet code; often confused with thrombocytosis |
A few coding points are worth knowing. When thrombocytosis is reactive, the underlying condition is usually coded as well, for example iron deficiency anemia or the infection behind it. The WHO’s international version of ICD-10 is organized a little differently from the US clinical modification, and code sets are updated every year. Coders should always check the current edition before submitting a claim.
Primary vs. Secondary Thrombocytosis
Deciding which type a patient has is the most important step, both clinically and for coding. It is part of the wider evaluation of hematological disorders that a hematologist carries out.
Primary (clonal) thrombocytosis
In primary thrombocytosis, the bone marrow overproduces platelets because of a defect in its own blood-forming stem cells. The main example is essential thrombocythemia (ET), a myeloproliferative neoplasm. Acquired mutations in the JAK2, CALR, or MPL genes drive the megakaryocytes, the marrow cells that make platelets, to multiply without the usual controls. These mutations develop during life and are not usually inherited. High platelet counts can also occur in other marrow disorders, including polycythemia vera, primary myelofibrosis, and chronic myeloid leukemia.
Secondary (reactive) thrombocytosis
Secondary thrombocytosis is far more common. The marrow itself is normal and is responding to signals from elsewhere in the body. Inflammatory cytokines, especially interleukin-6, raise thrombopoietin levels and speed up platelet production. Common triggers include:
- Acute infections and chronic infections such as tuberculosis
- Inflammatory conditions such as rheumatoid arthritis or inflammatory bowel disease
- Iron deficiency, often from blood loss
- Recent surgery, trauma, or burns
- Removal of the spleen (splenectomy), since the spleen normally stores and clears platelets
- Some cancers
Symptoms and Complications
Most people with a high platelet count have no symptoms, and the finding turns up on a routine blood test. When symptoms do occur, they are more likely in clonal disease. They include headaches, dizziness, visual disturbances, and burning or tingling in the hands and feet (erythromelalgia). The more serious complications are blood clots in arteries or veins, which can cause a stroke, heart attack, or deep vein thrombosis.
Very high counts, usually above about 1,000,000/µL, can actually cause bleeding. This happens because large numbers of platelets absorb von Willebrand factor, a clotting protein, and produce acquired von Willebrand syndrome. Platelet dysfunction in myeloproliferative neoplasms can also lead to bruising or bleeding from the gums and nose.
How the Cause Is Diagnosed
An elevated platelet count on a complete blood count (CBC) is the starting point. The usual next steps are:
- Repeat the CBC to confirm the count is still high, and look at a blood smear.
- Check for reactive causes: ferritin and iron studies, C-reactive protein (CRP), and the erythrocyte sedimentation rate (ESR).
- Review the history for recent infection, surgery, splenectomy, or signs of an inflammatory disease or cancer.
- Test for mutations (JAK2 V617F, CALR, MPL) if the count stays high and no reactive cause is found.
- Bone marrow biopsy when a myeloproliferative neoplasm is suspected, to confirm the diagnosis and rule out related conditions.
In my practice, it is common for the platelet count to fall back to normal once iron deficiency or an infection is treated. When that happens, the case is settled and no marrow tests are needed.
Treatment and Management
Treatment depends on the cause, not on the number alone.
- Secondary thrombocytosis: treat the underlying condition. Reactive thrombocytosis on its own rarely causes clots, and it seldom needs platelet-lowering drugs.
- Essential thrombocythemia: treatment is based on the risk of clots. Older age and a past thrombosis both count as high risk. Low-dose aspirin is often used, and hydroxyurea or other cytoreductive drugs such as anagrelide or interferon are added for higher-risk patients.
- Cardiovascular risk factors: managing blood pressure, cholesterol, diabetes, and smoking is part of care for everyone with clonal disease.
Key Takeaways
- Thrombocytosis means a platelet count above 450,000/µL.
- In ICD-10-CM, use D75.839 for an unexplained high count, D75.838 for reactive thrombocytosis, and D47.3 for essential thrombocythemia. D75.1 is not a platelet code.
- Most high counts are reactive and settle once the cause is treated.
- If the count stays high with no clear cause, the next steps are mutation testing and a hematology referral.
Frequently Asked Questions
What is the ICD-10 code for a high platelet count?
In ICD-10-CM, D75.839 covers thrombocytosis with no specified cause, and D75.838 covers other (including reactive) thrombocytosis. Essential thrombocythemia is coded D47.3. Always check the current annual code set, because codes are revised.
Is D75.1 the code for thrombocytosis?
No. D75.1 is secondary polycythemia, meaning too many red blood cells made in response to another condition. Using it for a high platelet count is a common mistake.
Should I worry about a platelet count of 500,000?
A mildly raised count like this is usually reactive, often due to a recent infection, inflammation, or low iron. Your doctor will normally repeat the test and look for a cause. A count that stays high with no explanation deserves further testing.
Can a high platelet count go away on its own?
Reactive thrombocytosis often returns to normal within weeks once the trigger resolves or is treated. Essential thrombocythemia is a long-term condition. It usually needs ongoing monitoring and, depending on risk, treatment.
